High demand puts pressure on Shingrix supply chain

Shingles vaccine
GSK expects to deliver 1.1 million doses of its shingles vaccine to the Commonwealth in the first half of 2024  Higher than anticipated demand for the National Immunisation Program (NIP) listed Shingrix vaccine is impacting the supply of the jab to pharmacies.  Since the launch of the NIP Vaccination in Pharmacy (NIPVIP) program on 1

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacies claim over $227k through NIPVIP in January
Next John Coppock Pharmacist Wellbeing Award launched